Company
Vico Therapeutics
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases
Also known as Vico Therapeutics B.V.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Headquarters
- Leiden, The Netherlands
- Founded
- 2019
- Legal name
- Vico Therapeutics B.V.
Claim, correct or request removal
Record updated 28 September 2026
About
Vico Therapeutics is a neurology genetic medicine company pioneering targeted treatments for devastating disorders. Our innovative antisense oligonucleotide (ASO) platform strikes at the root cause of these diseases – the CAG repeat expansion mutation – while carefully preserving essential protein function.
Funding snapshot
- Total raised
- $60MSum of rounds, as of 2026-09-19Source (opens in a new tab)
- Latest round
- Series B, $60M2024-01-05
Funding rounds
- Series B
- $60M2024-01-05, Company stated
Products
- Other
- VO659
Loading relationship preview